Loading…

Structure and Functions of CD23

This review summarizes recent data on CD23, a low affinity receptor for IgE (Fc RII). CD23 is the only FcR which does not belong to the immunoglobulin gene superfamily. The CD23 molecule was discovered independently as an IgE receptor on human lymphoblastoïd B cells [1], as a cell surface marker exp...

Full description

Saved in:
Bibliographic Details
Published in:International reviews of immunology 1997, Vol.16 (1-2), p.113-128
Main Authors: Bonnefoy, Jean-Yves, Lecoanet-Henchoz, Sybille, Gauchat, Jean-Francois, Graber, Pierre, Aubry, Jean-Pierre, Jeannin, Pascale, Plater-Zyberk, Christine
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This review summarizes recent data on CD23, a low affinity receptor for IgE (Fc RII). CD23 is the only FcR which does not belong to the immunoglobulin gene superfamily. The CD23 molecule was discovered independently as an IgE receptor on human lymphoblastoïd B cells [1], as a cell surface marker expressed on Epstein-Barr-Virus-transformed B cells (EBVCS) [2] and as a B-cell activation antigen (Blast 2) [3]. CD23 was shown to be a low affinity receptor for IgE [4,5]. Similar to most FcR, soluble forms of CD23 (sCD23) are released into extracellular fluids. The soluble fragments formed by proteolytic cleavage of surface CD23 are not only capable of binding IgE (IgE binding factors) but also exhibit multiple functions that are not IgE related. These observations together with the finding that CD23 displays significant homology with Ca2+-dependent (C-type) animal lectins, suggested the existence of natural ligands other than IgE. The recent finding that CD23 interacts with CD21, GD11b and CD1 1c indicates that CD23 should be viewed not only as a low affinity IgE receptor but also as an adhesion molecule involved in cell-cell interaction. After a brief overview of the molecular structure, there follows a discussion of the biological activities ascribed to human CD23.
ISSN:0883-0185
1563-5244
DOI:10.3109/08830189709045705